3 results
Approved WMORecruitment stopped
To evaluate the effects of intranasal oxytocin versus placebo on social behaviour and also on eating behaviour in children with PWS.
Approved WMORecruitment stopped
The primary objective is to explore the efficacy of nintedanib (as measured by progression free survival) as second line therapy for patients with either differentiated or medullary thyroid cancer progressing after first line therapy.
Approved WMOPending
To evaluate the effects of N-acetylcysteine (NAC; FluimucilĀ® in Dutch) on skin picking behaviour in children and young adults with PWS.